Effectiveness of Bebtelovimab Against Hospitalization and Death From the Omicron BA.4/BA.5 and BQ.1/BQ.1.1 Subvariants.

Wang, Xiaofeng; Fadel, Francois Abi; Huang, Shuaiqi; Sacha, Gretchen L; Bartley, Patricia; Duggal, Abhijit; Lin, Dan-Yu

Wang, Xiaofeng; Fadel, Francois Abi; Huang, Shuaiqi; Sacha, Gretchen L; Bartley, Patricia; Duggal, Abhijit; Lin, Dan-Yu.

Afiliação

Wang X; Department of Qualitative Health Sciences, Cleveland Clinic, Cleveland, OH.
Fadel FA; Department of Critical Care Medicine, Respiratory Institute, Cleveland, OH.
Huang S; Department of Qualitative Health Sciences, Cleveland Clinic, Cleveland, OH.
Sacha GL; Department of Pharmacy, Cleveland Clinic, Cleveland, OH.
Bartley P; Department of Infectious Disease, Respiratory Institute, Cleveland, OH.
Duggal A; Department of Critical Care Medicine, Respiratory Institute, Cleveland, OH.
Lin DY; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC. Electronic address: lin@bios.unc.edu.

Chest ; 164(4): 872-874, 2023 10.

Article em En | MEDLINE | ID: mdl-37414096

Assuntos

Tratamento Farmacológico da COVID-19; COVID-19; Hospitalização; Humanos; COVID-19/mortalidade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Tratamento Farmacológico da COVID-19 / Hospitalização Limite: Humans Idioma: En Revista: Chest Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google